Mark D. Pegram is the director of the Breast Cancer Oncology Program at Stanford Women’s Cancer Center. Dr. Pegram earned his undergraduate and medical degrees from the University of North Carolina and worked at University of California, Los Angeles and the University of Miami Miller School of Medicine before moving to Stanford. He is a renowned clinician and scholar in breast cancer research and a leader in translational medicine. Dr. Pegram played a major role in developing the drug Herceptin® as a treatment for HER2- positive breast cancer. His work showing that Herceptin ® improved survival rates and even cured some patients with breast cancer is of paramount importance, not only for the emergence of personalized medicine therapy in breast cancer, but also highlighting the significance of the translational research.

Dr. Harit Chaturvedi is the Chief Consultant and Director of Surgical Oncology at Max HealthCare, leading a team of 80 oncologists spread over 7 multi-specialty centers. He has a rich experience of over 3 decades in Oncology. He received his MBBS and MS degrees from G.S.V.M Medical College, Kanpur and M.Ch. (Surgical Oncology) from M.G.R. Medical University, Chennai. He has worked at several specialty cancer centers in India including Kidwai Memorial Institute, Bengaluru, Adyar Cancer Center (Chennai) and the Rajiv Gandhi Cancer Institute (Delhi).

Being a crusader against Tobacco for the last 15 years through various cancer foundations, Dr. Chaturvedi has been championing the cause for cancer awareness. His ability to nurture young talent has earned him the reputation as a teacher and mentor. He has performed surgeries at live surgical workshops, presented his work in national and international conferences and has over 50 publications in peer reviewed journals. He is a keen champion of research initiatives in India.

Dr Chaturvedi has served the national bodies like Indian Society of Oncology and Indian Association of Surgical Oncology as President. His ability to create a grand vision and execute it, was once again demonstrated at the national level, when he built the brand of Indian Cancer Congress, as its first organising secretary.

Dr. Sudeep Gupta completed his MBBS, MD and DM from the All India Institute of Medical Sciences (AIIMS), New Delhi, in the year 2000 and has been a faculty member in the Department of Medical Oncology at Tata Memorial Centre since then. He has been a prolific clinical researcher who is actively involved in planning, organizing, conducting and analyzing Phase I, II and III clinical trials and has been a Principal Investigator or Co-investigator in more than 100 trials. He takes special interest in breast and gynecological cancers and early drug development. His research areas have involved implementation science including access to medications, guideline development, testing concepts and technology in clinical trials, innovative therapeutic strategies, toxicity and quality-of-life studies, pharmacokinetics and translational studies involving next-generation sequencing technology. He has published more than 120 papers in peer reviewed journals. Since 2013 he has been the Deputy Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), one of the premier cancer translational research centres in India. He is currently engaged in facilitating cross-talk between various stakeholders in cancer research at the institutional and national level including basic scientists, clinical researchers, computational biologists, physicists, engineers and others.

Dr. Gouri Shankar Bhattacaryya has been conferred with FAcadTM, F-ASPET, RCOG Associate, Fellow American College Clinical Pharmacology. He has completed his education and training Medical Oncology from England. His line of special interest has been – Biological Response Modifiers and Tumor Microenvironment. His principal interest is in Solid Tumors – G.I., Breast and Lung, repurposing of drugs. He is a member of the Task Force for Management of Cancer at the Indian Council for Medical Research (Government of India) as well as a member of the Planning Committee of the National Cancer Control Program. He is the founder member of Indian Cooperative Oncology Network (ICON), Molecular Oncology Society, Indian Association of Cancer Research. He is also the founder Member of ICON Biorepository as well as member for Drafting of SOPs. He is President of Indian Society of Medical & Pediatric Oncology. He is Advisory Council Member of the Breast International Group (BIG) as well as member of BIGNorth American Breast Cancer Group (BIG-NABCG) and Drafting Committee Member of Consent Guidelines for Biorepository. He is the Chairman of SIOG Publication Committee. He is Editorial Member of Journal of Thoracic Oncology (JTO), Journal of Geriatric Oncology, Critical Reviews in Oncology / Hematology (CROH), Journal of Global Oncology–ASCO, Journal of Annals of Translational Medicine. He has special interest in Palliative care and Geriatric Oncology. He was awarded Certificate of recognition for Promotion and Development of Palliative Care in the World in 2013, by International Association for Hospice & Palliative Care (IAHPC). He has published more than 200 papers and has been an Investigator for more than 50 Phase II and III Clinical Trials done including Translational Research. He is holder of Orphan Drug status with FDA for Hepato- cellular carcinoma and Pancreatic Cancer, based on Investigator initiated trials.

Dr. Somashekhar S. P. is Chairman & HOD Surgical Oncology, Robotic Surgeon and Hipec Super Specialist at Manipal Comprehensive Cancer Center in Bengaluru. He is also a member of board of studies, Manipal University and a member of Business Advisory Board, MHEPL. His qualifications include MBBS from Mysore University, MS (Gen. Surgery) from NHL Medical College, MCh (Surgical Oncology) from GCRI, Fellowships from Fellow of Royal College of Surgeons (FRCS) from Edinburgh, Robotic Surgery Fellowship from Roswell Cancer Center from Buffalo in USA, Minimal Invasive Gynec Onco Fellowship IRCAD from Taiwan, Advanced Liver fellowship from Paul-Brousse Hospital in Paris, Clinical fellow Gynec Oncology from Mayo Clinic in Rochester, Clinical Fellow Breast surgery from University of Pittsburg Medical Centre Pittsburg in USA, Clinical Fellow Liver Surgery from Taipei in Taiwan, Robotic Surgery Fellowship from University of South Florid (USF) from Tampa in USA and Clinical Fellow Oncology from Todd Cancer Centre in Long Beach in USA.,. He received the Millenium Gold Medal Award in 2006 ASI, SSB for his work in Sentinel Lymph Node. Dr. Somashekher is a recipient of the prestigious Dr. D. D. Patel Gold Medal in Oncosurgery. He is the first in India to initiate a Robotic Scarless Thyroidectomy programme & TORS and has done the highest number of Robotic Complex Oncosurgeries in India.

Dr. DC Doval is the Chair of Medical Oncology & Chief of Breast & Thoracic services at the Rajeev Gandhi Cancer Institute (RGCI&RC) in Delhi. Dr. Doval carries an experience of more than 37 years in Medical Oncology. He specializes in the treatment of solid tumours, with a particular focus on patients with cancers of breast and lung.

During his career he has focused on helping patients manage their symptoms and improving their quality of life. As a part of this effort he has developed new models for the delivery of oncology care that provide medical excellence in settings convenient for patients and their families.

In the field of clinical research, he has participated in more than 60 international and national studies. He pioneered the first Phase 1 study in Oncology in India and has taken up anticancer drug development. He has also been involved in conducting efficacy and safety studies for many indigenously developed biosimilar molecules in India.

He has been involved in teaching Oncology specially Medical Oncology since and started the DNB course in Medical Oncology at RGCI&RC. Dr. Doval is a recipient of Medical Excellence award by Wockhardt India Limited and Howard medical International in Feb 2005, Chikitsa Siromani Award of International Study Circle in 2008, Panna Lal Oration IMA Aligarh and Chairman’s Award RGCIRC Excellence in Clinical Research 2011

Dr Sharma is the Director & Professor of Surgical Oncology at the Asian Institute of Oncology, Mumbai. He has worked at the Tata Memorial Hospital for over 27 years as professor. He trained extensively at Memorial Sloan Kettering Cancer Centre New York, and also trained at Japan's Kurume university & Fukuoka University on surgery for cancer of esophagus. Dr Sanjay Sharma has published over 100 articles in reputed medical journals, written one book on breast cancer, written may chapters in other medical books. He has given over 2000 guest lectures , symposiums, orations in India and abroad on cancer of the esophagus, lung, breast, stomach, GI tract, pancreas and cervix.

Dr. Sharma has been Principal investigator and Co-Investigator in multiple trials in cancer treatment in India and abroad. He has been a member of many societies like American College of Surgeons, International College of Surgeons and Indian College of Surgeons. He has been president of Indian Society of Oncology, President of Association of Indian Society of Surgical Oncologist, President of Indian Breast Group, Secretary of Indian Society of Esophageal diseases. He is also advisor and member of editorial board of many national & international journals.

Dr. Sharma has conducted many social service camps and arranged free cancer detection camps, breast clinics, educational lectures for general public and medical practitioners all over India. He is the Founder Secretary for Grameen Kark Rog Ujagar Yojna. (Rural Cancer Detection Program), conducting camps all across India, mainly Madhya Pradesh, Maharashtra & Chhattisgarh.